Document is current
Any future updates will be listed below
-
Authors
Nakahira, Hiroko
Takeuchi, Yoji
Shimamoto, Yusaku
Ishiguro, Shingo
Yunokizaki, Hiroshi
Ezoe, Yasumasa
Fujisawa, Fumie
Ishihara, Ryu
Takayama, Tetsuji
Yoshida, Teruhiko
Mutoh, Michihiro
Ishikawa, Hideki
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (22ck0106556h0003)
Japan Agency for Medical Research and Development (22ck0106556h0003)
Japan Agency for Medical Research and Development (22ck0106556h0003)
Japan Agency for Medical Research and Development (22ck0106556h0003)
- License Information
-
More Information
Article History
Received: 28 December 2022
Accepted: 3 October 2023
First Online: 27 November 2023
Declarations
:
: This study was approved by the Institutional Review Board of Osaka International Cancer Institute (2018–18229 and 2019–19006). Informed consent was obtained in the form of an opt-out on the institutional websites. The study was performed in accordance with the guidelines of the World Medical Association’s Declaration of Helsinki. All authors consent to publish this manuscript.
: Not applicable.
: Yoji Takeuchi has received honoraria for lectures from Olympus, Boston Scientific Japan, Daiichi-Sankyo, Miyarisan Pharmaceutical, Asuka Pharmaceutical, AstraZeneca, EA Pharma, Zeria Pharmaceutical, Fujifilm, Kaneka Medix, and Kyorin Pharmaceutical. The other authors declare that they have no competing interests.
